The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of anti-CTGF human recombinant monoclonal antibody pamrevlumab on resectability and resection rate when combined with gemcitabine/nab-paclitaxel in phase 1/2 clinical study for the treatment of locally advanced pancreatic cancer patients.
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Abbvie; Amgen; Gilead Sciences; Johnson & Johnson
Consulting or Advisory Role - Abbvie; Cornerstone Pharmaceuticals; Gilead Sciences; Halozyme
Research Funding - Aduro Biotech; Celgene; FibroGen; Immunomedics; OncoMed
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera
Honoraria - Caris Life Sciences; Celgene; Merrimack; Sirtex Medical
Consulting or Advisory Role - AstraZeneca/MedImmune; Caris Life Sciences; Celgene; Perthera; RenovoRx; Sirtex Medical
Research Funding - ARMO BioSciences (Inst); Bavarian Nordic (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); Curegenix (Inst); FibroGen (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Caris Life Sciences; Perthera; Sirtex Medical
 
Kabir Mody
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Genentech/Roche; Merrimack; Vicus Therapeutics
Research Funding - Agios; ARIAD; ArQule; FibroGen; MedImmune; Senhwa Biosciences; Taiho Pharmaceutical; TRACON Pharma
 
Jordan Michael Winter
No Relationships to Disclose
 
John A. Glaspy
Consulting or Advisory Role - FibroGen
Research Funding - FibroGen (Inst)
 
Tim Larson
No Relationships to Disclose
 
Marc Ryan Matrana
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; EMD Serono; Pfizer; Strata Oncology
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech; Merck; Sirtex Medical
 
Khalil Saikali
Employment - FibroGen
Stock and Other Ownership Interests - FibroGen
 
Mairead Carney
Employment - FibroGen
Stock and Other Ownership Interests - FibroGen
 
Seth Porter
Employment - FibroGen
Stock and Other Ownership Interests - FibroGen
Patents, Royalties, Other Intellectual Property - FibroGen
 
Peony Yu
Employment - Fibrogen
Leadership - FibroGen
Stock and Other Ownership Interests - Fibrogen
 
Elias Kouchakji
Employment - FibroGen
Leadership - FibroGen
Stock and Other Ownership Interests - FibroGen
 
Ewa Carrier
Employment - FibroGen
Stock and Other Ownership Interests - FibroGen
Consulting or Advisory Role - Taro
Patents, Royalties, Other Intellectual Property - UCSD